149 related articles for article (PubMed ID: 34443383)
1. Quantitative Structure-Activity Relationship Evaluation of MDA-MB-231 Cell Anti-Proliferative Leads.
Gandhi A; Masand V; Zaki MEA; Al-Hussain SA; Ghorbal AB; Chapolikar A
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443383
[TBL] [Abstract][Full Text] [Related]
2. Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modelling.
Masand VH; Rastija V; Patil MK; Gandhi A; Chapolikar A
SAR QSAR Environ Res; 2020 Sep; 31(9):643-654. PubMed ID: 32847369
[TBL] [Abstract][Full Text] [Related]
3. QSAR analysis of sodium glucose co-transporter 2 (SGLT2) inhibitors for anti-hyperglycaemic lead development.
Gandhi A; Masand V; Zaki MEA; Al-Hussain SA; Ghorbal AB; Chapolikar A
SAR QSAR Environ Res; 2021 Sep; 32(9):731-744. PubMed ID: 34494464
[TBL] [Abstract][Full Text] [Related]
4. 2D- and 3D-QSAR modelling, molecular docking and
Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
[TBL] [Abstract][Full Text] [Related]
5. Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study.
Masand VH; Akasapu S; Gandhi A; Rastija V; Patil MK
Chemometr Intell Lab Syst; 2020 Nov; 206():104172. PubMed ID: 33518858
[TBL] [Abstract][Full Text] [Related]
6. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.
Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I
Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153
[TBL] [Abstract][Full Text] [Related]
7. QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA.
Jawarkar RD; Bakal RL; Mukherjee N; Ghosh A; Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Samad A; Gandhi A; Masand VH
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897936
[TBL] [Abstract][Full Text] [Related]
8. New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
Fu Y; Sun YN; Cao HF; Yi KH; Zhao LX; Li JZ; Ye F
Comb Chem High Throughput Screen; 2017; 20(9):748-759. PubMed ID: 28637410
[TBL] [Abstract][Full Text] [Related]
9. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
10. Quinoxalinones Based Aldose Reductase Inhibitors: 2D and 3D-QSAR Analysis.
Masand VH; Elsayed NN; Thakur SD; Gawhale N; Rathore MM
Mol Inform; 2019 Aug; 38(8-9):e1800149. PubMed ID: 31131980
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
Ahmadinejad N; Shafiei F
Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
[TBL] [Abstract][Full Text] [Related]
12. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761
[TBL] [Abstract][Full Text] [Related]
13. Structure-based quantitative structure-activity relationship studies of checkpoint kinase 1 inhibitors.
Du J; Xi L; Lei B; Lu J; Li J; Liu H; Yao X
J Comput Chem; 2010 Nov; 31(15):2783-93. PubMed ID: 20839304
[TBL] [Abstract][Full Text] [Related]
14. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
[TBL] [Abstract][Full Text] [Related]
15. QSAR study on melanocortin-4 receptors by support vector machine.
Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
Eur J Med Chem; 2010 Mar; 45(3):1087-93. PubMed ID: 20031282
[TBL] [Abstract][Full Text] [Related]
16. QSAR Models for Predicting Aquatic Toxicity of Esters Using Genetic Algorithm-Multiple Linear Regression Methods.
Rajabi M; Shafiei F
Comb Chem High Throughput Screen; 2019 Aug; 22(5):317-325. PubMed ID: 31215375
[TBL] [Abstract][Full Text] [Related]
17. Blood-brain barrier permeability mechanisms in view of quantitative structure-activity relationships (QSAR).
Bujak R; Struck-Lewicka W; Kaliszan M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015 Apr; 108():29-37. PubMed ID: 25703237
[TBL] [Abstract][Full Text] [Related]
18. Comparison of MLR, PLS and GA-MLR in QSAR analysis.
Saxena AK; Prathipati P
SAR QSAR Environ Res; 2003; 14(5-6):433-45. PubMed ID: 14758986
[TBL] [Abstract][Full Text] [Related]
19. Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling.
Aboalhaija NH; Zihlif MA; Taha MO
Chem Biol Interact; 2016 Apr; 250():12-26. PubMed ID: 26954606
[TBL] [Abstract][Full Text] [Related]
20. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
